Lager Joanne Jenkins 4
4 · iTeos Therapeutics, Inc. · Filed Mar 14, 2022
Insider Transaction Report
Form 4
Lager Joanne Jenkins
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2022-03-11$4.30/sh+3,500$15,050→ 3,500 total - Sale
Common Stock
2022-03-11$36.01/sh−3,500$126,035→ 0 total - Award
Stock Option (Right to Buy)
2022-03-11+85,000→ 85,000 totalExercise: $36.21Exp: 2032-03-11→ Common Stock (85,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-11−3,500→ 178,938 totalExercise: $4.30Exp: 2025-06-11→ Common Stock (3,500 underlying)
Footnotes (2)
- [F1]This stock option shall vest over 4 years, with 25% vesting on March 11, 2023 and thereafter in equal monthly installments over the next 36 months, subject to the Reporting Person's continued service to the Issuer.
- [F2]One-fourth of the shares subject to the stock option vested on April 1, 2020. Thereafter, 1/48 of the shares subject to the stock option vest on a monthly basis, subject to the reporting person's continuous service relationship with the Issuer through each applicable vesting date